A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer

NCT00001338 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

65

Enrollment

NIH

Sponsor class

Conditions

Breast Neoplasms
Fever
Hematologic Diseases
Neutropenia
Sepsis

Interventions

DRUG: FLAC chemotherapy with GM-CSF

Sponsor

National Cancer Institute (NCI)